Search Results - "Buonanno, M. T."

TIXAGEVIMAB‐CILGAVIMAB THERAPY IN THE PREVENTION OF SARS‐COV2 INFECTION IN NON HODGKIN‐B LYMPHOMAS AND HODGKIN LYMPHOMAS UNDER TREATMENT: OUR EXPERIENCE by Pezzullo, L., Giudice, V., D'Addona, M., Buonanno, M. T., Novellis, D., Ferrara, I., Fontana, R., Guariglia, R., Luponio, S., Martorelli, M. C., Mettivier, L., Serio, B., Selleri, C.

Get full text

Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma by Catalano, Lucio, Andretta, Claudia, Pace, Leonardo, Del Vecchio, Silvana, Salvatore, Barbara, De Rosa, Gennaro, Buonanno, Maria Teresa, Paone, Gaetano, Rotoli, Bruno

“…Staging and monitoring of multiple myeloma (MM) is mainly based on monoclonal component quantification; the absence of such a parameter renders difficult…”
Get more information